Abstract Key Points 1 Liver failure and liver cancer from chronic hepatitis C are the most
common indications for liver transplantation and numbers of both are projected to double …

Key Points 1. Recurrence of hepatitis C infection is universal and immediate after liver
transplantation. 2. Graft and patient survival is reduced in liver transplantation recipients with …

Background. The yearly increasing survival rates testify to the success of transplantation, but
questions remain relating to the quality of life (QOL) associated with long-term survival …

Background Liver transplantation (LT) offers a possible cure for carefully selected patients
with hepatocellular carcinoma (HCC). Studies report that preoperative alpha‐fetoprotein …

Orthotopic liver transplantation (OLT) selection for patients with hepatocellular carcinoma
(HCC) is a matter of debate. The Milan criteria (MC) have been largely adopted by the …

We assessed the impact of liver transplantation (LT) on the quality of life (QOL) of French
recipients 1 year after surgery. A French version of the questionnaire used by the National …

Improved outcome after liver transplantation (LTX) for hepatocellular carcinoma (HCC)
made LTX a legitimate treatment of the disease. We analyzed trends of LTX for HCC with …

The incidence of hepatocellular carcinoma (HCC) is on the rise worldwide as the most
common primary hepatic malignancy. In the US approximately one half of all HCC is related …

Key Points 1. The natural history of hepatitis C after liver transplantation is variable. Several
factors, including those related to the virus, the host, the environment and the donor, are …

Long-term graft survival and mortality after liver transplantation continue to improve.
However, disease recurrence remains a major stumbling block, especially among patients …